PTX Related Analyst Ratings
-
Cantor Fitzgerald Downgrades Pernix Therapeutics (PTX) to Hold
-
Guggenheim Starts Pernix Therapeutics (PTX) at Buy
-
Needham & Company Maintains a 'Buy' on Pernix Therapeutics (PTX); Don't Call It A Comeback
-
Needham & Company Maintains a 'Buy' on Pernix Therapeutics (PTX); Price Increase On Cedax Franchise Provides Solid Near-Term Buffer
-
Pernix Therapeutics (PTX) Shares Spike - Acquires Great Southern Labs and Looking For More
-
Canaccord Genuity Reiterates a 'Buy' on Pernix Therapeutics (PTX); Acquisition to Immediately Benefit Gx Gross Margin
-
Needham & Company Maintains a 'Buy' on Pernix Therapeutics (PTX); Acquisition Adds Strategic Muscle On Manufacturing & Development Side
-
Canaccord Genuity Reiterates a 'Buy' on Pernix Therapeutics (PTX); Tough Q1, But Thesis Remains Intact
-
Needham & Company Maintains a 'Buy' on Pernix Therapeutics (PTX); Upside Scenarios Outweigh Downside Risks
-
Canaccord Genuity reiterates a 'Buy' on Pernix Therapeutics (PTX); Unique Small-Cap with Expected Strong Yield
-
Cantor Fitzgerald Raises Price Target on Pernix Therapeutics (PTX) After Positive Management Meeting
-
Canaccord Genuity Reiterates a 'Buy' on Pernix Therapeutics (PTX); Solid Q4, Execution & Business Development The Focus
-
Needham & Company Maintains a 'Buy' on Pernix Therapeutics (PTX); Adjusting Estimates After Q4 Results
-
Needham & Company Maintains a 'Buy' on Pernix Therapeutics (PTX); Continues Winning Top Line Ways
-
Canaccord Genuity Reiterates a 'Buy' on Pernix Therapeutics (PTX); Management Execution on Business Development Strategy Continues
-
Canaccord Genuity on Life Sciences/Specialty Pharmaceuticals: Three Small-Cap Buy Ideas for 2012
-
Canaccord Genuity Starts Pernix Therapeutics (PTX) at Buy; Robust Growth with Business Fevelopment to Further Fuel P&L Upside
-
Canaccord Genuity Starts Pernix Therapeutics (PTX) at Buy
-
Cantor Fitzgerald Starts Pernix Therapeutics (PTX) at Buy, Stocks Undervalued Based on Pipeline Outlook
-
Needham & Company: Specialty Pharmaceuticals - 2012 Preview: European Hangover Expected to Ease; Valuations Reflect Fear Not Fact
-
Needham & Company Starts Pernix Therapeutics (PTX) at Buy; Kid is Hot Tonight; Hitting Stride as Recent Launches Provide Leverage
-
Stifel Nicolaus Starts Pernix Therapeutics (PTX) at Buy
-
Morgan Joseph Starts Pernix Therapeutics (PTX) at Buy; Profitability and Sustainable Cash Flows
-
Duncan Williams Starts Pernix Therapeutics (PTX) at Buy; Colds, Coughs, Lice, Oh My!
Back to PTX Stock Lookup
